FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 304:380-386 February 12, 1981 Number 7 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

To study the efficacy of corticosteroids in chronic active hepatitis (CAH) positive for hepatitis B surface antigen (HBsAg), we pair-randomized 51 patients to receive either 15 to 20 mg of prednisolone per day or a placebo. After initial remission, the maintenance dosage of prednisolone was 10 mg per day, and the patients were prospectively followed for up to 3 1/2 years. Prednisolone decreased serum bilirubin (P < 0.05) and globulin (P < 0.01) at three months; it delayed other biochemical remission occurring after the second month of medication (P < 0.001); it hastened biochemical relapse (P < 0.0001); and it increased the frequency of complications (P < 0.0001) and the death rate (P < 0.01). We conclude that prednisolone has an overall harmful effect in patients with HBsAg-positive CAH.

This article has been cited by other articles:

• McGee, S., Hirschmann, J. (2008). Use of Corticosteroids in Treating Infectious Diseases. Arch Intern Med 168: 1034-1046 [Abstract] [Full Text]  
• Ramos-Casals, M., Trejo, O., Garcia-Carrasco, M., Font, J. (2003). Therapeutic management of extrahepatic manifestations in patients with chronic hepatitis C virus infection. Rheumatology (Oxford) 42: 818-828 [Full Text]  
• Stone, J. H. (2002). Polyarteritis Nodosa. JAMA 288: 1632-1639 [Abstract] [Full Text]  
• Filer, A., Hughes, A., Kane, K., Mutimer, D., Jobanputra, P., Maclachlan, D., Battegay, M., Jacob, A. L., Tyndall, A. (2001). Successful treatment of hepatitis B-associated vasculitis using lamivudine as the sole therapeutic agent. Rheumatology (Oxford) 40: 1064-1065 [Full Text]  
• Maclachlan, D., Battegay, M., Jacob, A. L., Tyndall, A. (2000). Successful treatment of hepatitis B-associated polyarteritis nodosa with a combination of lamivudine and conventional immunosuppressive therapy: a case report. Rheumatology (Oxford) 39: 106-108 [Full Text]